INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH
INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH
June 10, 2025 at 02:07 AM
🫁 Tuberculosis 🫁 (TB) remains a global health threat, caused by Mycobacterium tuberculosis, primarily affecting the lungs. However, Extrapulmonary Tuberculosis (EPTB) — TB infection outside the lungs — can involve the brain, lymph nodes, bones, and other organs. Its varied symptoms make detection and treatment more complex. 📌 Key Highlights on EPTB Advances: ⭕ Challenging Diagnosis & Management: Diverse manifestations make EPTB harder to diagnose and treat than pulmonary TB. ⭕ New-Age TB Drugs: ▶️ Bedaquiline, delamanid, and pretomanid are improving outcomes in drug-resistant TB, including EPTB cases. ⭕ Supportive Therapies: ▶️ Use of corticosteroids, interferon-gamma, and vitamin D supplements in severe TB meningitis and pericarditis helps manage inflammation and immune response. ⭕ Targeted Drug Delivery: ▶️ Nanoparticles and liposomes boost drug bioavailability and reduce side effects by delivering drugs directly to infection sites. ⭕ Treatment in Low-Resource Settings: ▶️ DOTS (Directly Observed Treatment, Short-course) improves patient compliance and outcomes. ⭕ Recent Advancements: ▶️ Molecular diagnostics (GeneXpert, LAMP assays) allow faster, more accurate detection. ▶️ AI-assisted imaging is emerging in EPTB diagnosis. ▶️ Shorter, personalized drug regimens based on genetic/resistance profiles are under development. 🫁 EPTB is a silent yet serious form of tuberculosis that demands early diagnosis and proper care. Stay informed, stay protected. 🫁 Read the full article here https://ijpsr.com/bft-article/significant-progress-in-the-treatment-of-extrapulmonary-tuberculosis-a-comprehensive-review to explore how science is transforming EPTB care—and how we can play a part in TB prevention and awareness. Together, we can stop TB—one step, one innovation, one precaution at a time. 🤝 Become a member of our dynamic LinkedIn community to stay informed about the latest trends in publishing, research, and pharmaceutical webinars. Access exclusive insights and opportunities that can elevate your career. Follow us today and start your journey with SPSR! https://www.linkedin.com/company/spsr2010
Image from INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH: 🫁 Tuberculosis 🫁  (TB) remains a global health threat, caused by Myc...
👍 2

Comments